APA

Jahn N., Agrawal M., Bullinger L., Weber D., Corbacioglu A., Gaidzik V. I., Schmalbrock L., Thol F., Heuser M., Krauter J., Göhring G., Kündgen A., Fiedler W., Wattad M., Held G., Köhne C., Horst H., Lübbert M., Ganser A., Schlenk R. F., Döhner H., Döhner K. & Paschka P. (20180601). Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group. : Leukemia.

Chicago

Jahn N, Agrawal M, Bullinger L, Weber D, Corbacioglu A, Gaidzik V I, Schmalbrock L, Thol F, Heuser M, Krauter J, Göhring G, Kündgen A, Fiedler W, Wattad M, Held G, Köhne C-H, Horst H-A, Lübbert M, Ganser A, Schlenk R F, Döhner H, Döhner K and Paschka P. 20180601. Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group. : Leukemia.

Harvard

Jahn N., Agrawal M., Bullinger L., Weber D., Corbacioglu A., Gaidzik V. I., Schmalbrock L., Thol F., Heuser M., Krauter J., Göhring G., Kündgen A., Fiedler W., Wattad M., Held G., Köhne C., Horst H., Lübbert M., Ganser A., Schlenk R. F., Döhner H., Döhner K. and Paschka P. (20180601). Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group. : Leukemia.

MLA

Jahn N, Agrawal M, Bullinger L, Weber D, Corbacioglu A, Gaidzik V I, Schmalbrock L, Thol F, Heuser M, Krauter J, Göhring G, Kündgen A, Fiedler W, Wattad M, Held G, Köhne C-H, Horst H-A, Lübbert M, Ganser A, Schlenk R F, Döhner H, Döhner K and Paschka P. Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group. : Leukemia. 20180601.